Breaking Research News from Breastcancer.org
Comments
-
FDA Approves Herceptin Biosimilar Trazimera to Treat HER2-Positive Breast Cancer
March 18, 2019
On March 11, 2019, the FDA approved Trazimera (chemical name: trastuzumab-qyyp), a biosimilar for Herceptin, to treat people diagnosed with HER2-positive breast cancer. Read more...0 -
Group Exercise Improves Quality of Life More Than Personal Training for Women Treated for Breast Cancer
March 18, 2019
Group exercise and personal training sessions both lead to similar physical gains, but a small study suggests that a group exercise program can boost quality of life more than personal training for women who've been treated for breast cancer. Read more...0 -
3D Mammography More Likely to Find Small Invasive Breast Cancers, Especially in Women Younger Than 50
March 18, 2019
Breast cancers found with 3D mammography were more likely to be smaller and node-negative compared to breast cancers found with standard digital mammography. Read more...0 -
Immigrant Asian Women Seem to Have Higher Risk of Breast Cancer Compared to U.S.-Born Asian Women
March 19, 2019
Asian-American women who had immigrated to the United States had a higher risk of breast cancer than Asian-American women born in the United States. Read more...0 -
High Out-of-Pocket Costs Lead to Delays in Breast Cancer Care for Low-Income Women
March 19, 2019
Women with lower incomes enrolled in health insurance plans with high deductibles are more likely to delay breast cancer care, including diagnostic mammograms, biopsies, and chemotherapy, according to a study. Read more...0 -
Formal Treatment Guidelines Developed for Rare Cancer Linked to Breast Implants
March 20, 2019
National Comprehensive Cancer Network treatment guidelines have been developed for breast implant-associated anaplastic large-cell lymphoma, a rare type of cancer linked to textured breast implants. Read more...0 -
FDA Warns Two Breast Implant Makers About Lack of Long-Term Studies, Will Review Implant Safety
March 21, 2019
The FDA has sent warning letters to two breast implant manufacturers because the companies have not conducted the post-approval long-term safety studies that were required as part of the implants' FDA approval. Read more...0 -
Advanced Breast Cancer Screening Methods Classify Fewer Women as Having Dense Breasts
March 22, 2019
When breast cancer screening uses advanced techniques such as 3D mammograms or synthetic mammograms, fewer women are found to have dense breasts compared to screening with traditional 2D mammography, according to a study. Read more...0 -
3D Mammography Reduces Breast Biopsy Rates
March 25, 2019
Using 3D mammography may reduce the number of women who have a biopsy for a suspicious lesion after an abnormal mammogram, according to a study. Read more...0 -
FDA Says Mammography Reports Should Provide More Information on Breast Density
March 28, 2019
Mammography centers would have to provide more information on breast density and how density affects breast cancer risk and the accuracy of mammograms, according to proposed FDA changes. Read more...0 -
Faslodex and Arimidex Better Than Arimidex Alone as First Treatment for Hormone-Receptor-Positive Metastatic Breast Cancer
April 2, 2019
Adding Faslodex to Arimidex as the first treatment for metastatic hormone-receptor-positive breast cancer improved overall survival by nearly 8 months compared to Arimidex alone, according to a study. Read more...0 -
Exercise Reduces Risk of Heart Disease in Women Treated for Early-Stage Breast Cancer
April 2, 2019
A structured exercise program of aerobic and weight-bearing exercise reduced the risk of heart disease in overweight or obese women diagnosed with early-stage breast cancer. Read more...0 -
Ibrance Approved to Treat Men With Advanced-Stage Hormone-Receptor-Positive Breast Cancer
April 5, 2019
The FDA has approved Ibrance to treat men diagnosed with advanced-stage hormone-receptor-positive, HER2-negative breast cancer. Read more...0 -
Surgery Linked to Better Survival for Metastatic HER2-Positive Breast Cancer
April 8, 2019
Women diagnosed with metastatic HER2-positive breast cancer lived longer if they had surgery to remove the primary tumor in the breast. Read more...0 -
Breast Surgeons Group Says Everyone Diagnosed With Breast Cancer Should Be Offered Genetic Testing
April 8, 2019
The American Society of Breast Surgeons says genetic testing should be made available to everyone who has been diagnosed with breast cancer. Read more...0 -
3D Mammograms More Effective Than 2D Mammograms in Women 65 and Older
April 9, 2019
Compared to traditional 2D mammograms, 3D mammograms offer fewer false positives and are more effective in women age 65 and older. Read more...0 -
More Than 20% of Women Diagnosed With Early-Stage Breast Cancer Stop Follow-Up Care Early
April 12, 2019
More than 20% of women diagnosed with stage I or stage II breast cancer stopped seeing a doctor for breast cancer follow-up care too soon. Read more...0 -
Switching to New Doctor Delays Breast Cancer Treatment
April 15, 2019
People newly diagnosed with non-metastatic breast cancer who switched their care to a different doctor had various treatments delayed by more than a week. Read more...0 -
Genetic Testing Rates Are Low in Women Diagnosed With Breast Cancer, Ovarian Cancer
April 18, 2019
Only about 25% of women diagnosed with breast cancer and about 31% of women diagnosed with ovarian cancer have genetic testing. Read more...0 -
Nutrients From Food, Not Supplements, Linked to Lower Risk of Death, Cancer
April 24, 2019
Getting sufficient amounts of certain nutrients from food, rather than dietary supplements, is linked to a lower risk of dying from any cause. Read more...0 -
Having a Partner Seems to Improve Quality of Life in Women With Sexual Side Effects From Breast Cancer Hormonal Therapy
April 25, 2019
A small study suggests that postmenopausal women with partners may have better quality of life than women without partners when experiencing a number of sexual side effects from hormonal therapy. Read more...0 -
Radiation Therapy Benefits All Early-Stage Hormone-Receptor-Positive Breast Cancer
May 2, 2019
Treating early-stage hormone-receptor-positive, HER2-negative breast cancer with a low risk of recurrence with both radiation therapy and hormonal therapy after lumpectomy lowers the risk of recurrence more than hormonal therapy alone. Read more...0 -
Kadcyla Approved to Treat Early-Stage HER2-Positive Breast Cancer
May 7, 2019
On May 3, 2019, the FDA approved Kadcyla to treat early-stage HER2-positive breast cancer after surgery if there were cancer cells found during surgery after neoadjuvant chemotherapy with a taxane and Herceptin. Read more...0 -
Six Factors Linked to Invasive Breast Cancer Recurrence After DCIS
May 6, 2019
After being diagnosed and treated for DCIS, six factors seem to be linked to a higher risk of recurrence of invasive breast cancer, according to a study. Read more...0 -
Chemotherapy Break Linked to Worse Outcomes for Advanced-Stage HER2-Negative Breast Cancer
May 7, 2019
A schedule of continuous chemotherapy for women diagnosed with advanced-stage HER2-negative breast cancer offered better overall survival and progression-free survival than a schedule with breaks from chemotherapy, with similar quality of life, according to a study. Read more...0 -
Bioimpedance Spectroscopy Seems Better Than Tape Measure for Detecting Lymphedema Early
May 8, 2019
Using bioimpedance spectroscopy to measure lymph fluid build-up seems better than using a tape measure to keep track of arm circumference for detecting lymphedema, according to interim study results. Read more...0 -
American Society of Breast Surgeons Issues Updated Breast Cancer Screening Guidelines
May 10, 2019
The American Society of Breast Surgeons' new breast cancer screening recommendations say women at average risk should start having annual mammograms at age 40. Read more...0 -
Feminizing Hormones Linked to Higher Breast Cancer Risk in Trans Women, but Risk Still Lower Than Average Woman's
May 17, 2019
Transgender women who take feminizing hormone therapy have a higher risk of breast cancer compared to the average man, according to a Dutch study. Still, this increase in risk is small and is not as high as the average woman's risk. Read more...0 -
Does a Low-Fat Diet Reduce the Risk of Dying From Breast Cancer?
May 17, 2019
The Women's Health Initiative Trial suggests that postmenopausal women who reduced the amount of fat they ate seem to have a 21% lower risk of dying from breast cancer. Read more...0 -
FDA Approves Piqray to Treat Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation
May 29, 2019
FDA approves Piqray in combination with Faslodex to treat metastatic and advanced-stage, hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation that has grown after hormonal therapy treatment in postmenopausal women and men. Read more...0
